Metabolic syndrome and nephrolithiasis: Can we hypotize a common background?

Clinical Cases in Mineral and Bone Metabolism

Volumn 5, Issue 2, 2008, Pages 114-117

  Mossetti, Giuseppe ^a   Rendina, Domenico ^a,b   De Filippo, Gianpaolo ^c   Benvenuto, Domenico ^b   Vivona, Carmen Liliana ^b   Zampa, Giorgia ^a   Ferraro, Pasquale ^b   Strazzullo, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Spinelli Hospital   (Italy)

^c G RUMMO HOSPITAL   (Italy)

Author keywords

Dietary habits; Gender; Insulin resistance; Metabolic syndrome; Nephrolithiasis; Vitamin D

Indexed keywords

ESTROGEN; INSULIN; VITAMIN D;

CHRONIC KIDNEY DISEASE; DIET; ESTROGEN SYNTHESIS; GENE INTERACTION; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEPHROLITHIASIS; OBESITY; SHORT SURVEY;

EID: 57149092430     PISSN: 17248914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (85)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
2. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - the Evidence Report. National Institutes of Health. Obes Res. 1998;6 (suppl 2):51S-209S.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
5. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
6. Grundy SM. Does the metabolic syndrome exist? Diabetes Care. 2006;29:1689-692.
7. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007;92:399-404.
8. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-36.
9. Gustat J, Srinivasan SR, Elkasabany A, et al. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J Clin Epidemiol. 2002;55:997-1006.
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
11. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404-11.
12. Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol. 2006;17:S81-S85.
13. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-174.
14. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: an independent clinical association in a population-based study. BMJ. 1990;300:1234-6.
15. Curhan GC, Willett WC, Rimm EB, et al. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9:1645-52.
16. Borghi L, Meschi T, Guerra A, et al. Essential arterial hypertension and stone disease. Kidney Int. 1999;55:2397-406.
17. Strazzullo P, Barba G, Vuotto P, et al. Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant. 2001;16:2232-5.
18. Tisler A, Pierratos A, Honey JD, et al. High urinary excretion of uric acid combined with high excretion of calcium links kidney stone disease to familial hypertension. Nephrol Dial Transplant. 2002;17:253-9.
19. Abate N, Chandalia M, Cabo-Chan AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004;65:386-92.
20. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230-5.
21. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005;46:263-9.
22. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;93:455-62.
23. Taylor EN, Mount DB, Forman JP, et al. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis. 2006;47:780-9.
24. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005;115:2598-608.
25. Miccoli R, Bianchi C, Odoguardi L, et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis. 2005;15:250-4.
26. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999;81(suppl 1):26.
27. Scales CD Jr, Curtis LH, Norris RD, et al. Changing gender prevalence of stone disease. J Urol. 2007;177:979-82.
28. Lieske JC, Pena de la Vega LS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69:760-4.
29. Mossetti G, Rendina D, De Filippo G, et al. Relationship between metabolic syndrome and nephrolithiasis in a cohort of caucasian subjects from southern Italy. Clin Case Miner Bone Metab. 2006;3(3):386-7.
30. Schwille PO, Schmiedt A, Herrmann U. Post prandial hyperinsulinaemia, insulin resistance and inappropriately high phosphaturia are features of younger males with idiopathic calcium urolithiasis: attenuation by ascorbicacid supplementation of a test meal. Urol Res. 1997;25:45-9.
31. Cupisti A, Meola M, D'Alessandro C, et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother. 2007;61:86-90.
32. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-49.
33. Abate N, Chandalia M, Snell PG, et al. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab. 2004;89:2750-5.
34. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a casecontrol study. Lancet. 2005;366:1640-9.
35. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48(6):905-15.
36. Maalouf NM, Sakhaee K, Parks JH, et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65(4):1422-5.
37. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-F28.
38. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017-29.
39. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005;31:318-25.
40. Kerstetter J, Caballero B, O'Brien K, et al. Mineral homeostasis in obesity: Effects of euglycemic hyperinsulinemia. Metabolism. 1991;40:707-13.
41. Maestro B, Campion J, Davila N, et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47:383-391.
42. Draznin B, Sussman K, Kao M, et al. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987;262:14385-8.
43. Draznin B, Sussman KE, Eckel RH, et al. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest. 1988;82:1848-52.
44. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325-49.
45. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542-8.
46. Maestro B, Dávila N, Carranza MC, et al. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2-3):223-30.
47. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143-56.
48. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371:1-12.
49. Rendina D, Mossetti G, Viceconti R, et al. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Urology. 2004;64:833-8.
50. Mossetti G, Rendina D, Viceconti R, et al. The relationship of 3′ vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis. Nephrol Dial Transplant. 2004;19:2259-65.
51. Mossetti G, Vuotto P, Rendina D, et al. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Intern Med. 2003;253:194-200.
52. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002;51(3):356-9.
53. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne′-Chantelot C, Timsit J, Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol. 2001;145(2):181-6.
54. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005;31(4 Pt 1):318-25.
55. Bergsland KJ, Kinder J, Asplin JR, et al. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002;167:2372-76.
56. Kato Y, Yamaguchi S, Kakizaki H, et al. Influence of estrus status on urinary chemical parameters related to urolithiasis. Urol Res. 2005;33:476-80.
57. Heller HJ, Sakhaee K, Moe OW, et al. Etiological role of estrogen status in renal stone formation. J Urol. 2002;168:1923-7.
58. Siener R. Impact of dietary habits on stone incidence. Urol Res. 2006;34(2):131-3.
59. Khaw K-T, Barrett-Connor E. The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation. 1988;77:53-61.
60. Cirillo M, Laurenzi M, Panarelli W, et al. Urinary sodium to potassium ratio and urinary stone disease. Kidney Int. 1994;46:1133-9.
61. Morris RC Jr, Schmidlin O, Frassetto LA, et al. Relationship and interaction between sodium and potassium. J Am Coll Nutr. 2006;25(3 Suppl):262S-70S.
62. Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med. 1985;312:283-9.
63. Frisancho AR, Leonard WR, Bollettino LA. Blood pressure in blacks and whites and its relationship to dietary sodium and potassium intake. J Chron Dis. 1984;37:515-9.
64. Friedman PA. Codependence of renal calcium and sodium transport. Annu Rev Physiol. 1998; 60:179-97.
65. Hoenderop JG, van der Kemp AW, Hartog A, et al. Molecular identification of the apical Ca2+ channel in 1,25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem. 1999;274:8375-8.
66. Blackwood AM, Sagnella GA, Cook DG, et al. Urinary calcium excretion, sodium intake and blood pressure in a multi-ethnic population: results of the Wandsworth Heart and Stroke Study. J Hum Hypertens. 2001;15:229-37.
67. Cirillo M, Ciacci C, Laurenzi M, et al. Salt intake, urinary sodium, and hypercalciuria. Miner Electrolyte Metab. 1997;23:265-8.
68. Sakhaee K, Harvey JA, Padalino PK, et al. The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993;150:310-2.
69. Timio F, Kerry SM, Anson KM, et al. Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003;12:122-7.
70. Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008, doi:10.1038/ajh.2007. 62.
71. Lemann J Jr, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans. Am J Physiol Renal Physiol. 2003;285:F811-32.
72. Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int. 2004;66:2402-10.
73. Allen LH, Oddoye EA, Margen S. Protein-induced hypercalciuria: a longer term study. Am J Clin Nutr. 1979;32:741-9.
74. Hegsted M, Linkswiler HM. Long-term effects of level of protein intake on calcium metabolism in young adult women. J Nutr. 1981;111:244-51.
75. Zemel MB, Schuette SA, Hegsted M, et al. Role of the sulfur-containing amino acids in protein-induced hypercalciuria in men. J Nutr. 1981;111:545-52.
76. Linkswiler HM, Zemel MB, Hegsted M, et al. Protein-induced hypercalciuria. Fed Proc. 1981;40:2429-33.
77. Lemann J Jr, Gray RW, Maierhofer WJ, et al. The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int. 1986;29:743-6.
78. Breslau NA, Brinkley L, Hill KD, et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140-6.
79. Reddy ST, Wang CY, Sakhaee K, et al. Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002;40:265-74.
80. Hiatt RA, Ettinger B, Caan B, et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996;144:25-33.
81. Cirillo M, Laurenzi M. Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens. 1988;6:S485-6.
82. Madore F, Stampfer MJ, Rimm EB, et al. Nephrolithiasis and risk of hypertension. Am J Hypertens. 1998;11:46-53.
83. Cappuccio FP, Siani A, Barba G, et al. A prospective study of hypertension and the incidence of kidney stones in men. J Hypertens. 1999;17:1017-22.
84. Strazzullo P, Galletti F, Cirillo M, et al. Altered extracellular calcium homoeostasis in essential hypertension: a consequence of abnormal cell calcium handling. Clin Sci (Lond). 1986;71:239-44.
85. Mente A, Honey RJ, McLaughlin JM, et al. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol. 2006;17:2567-75.